Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001209191-24-003031

10% owner sold 1,000 shares at $0.64 ($640)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Atlas Venture Fund XI, L.P. 10% owner 2024-02-08 Sale −733 $0.64 $469 2,019,563 D
Atlas Venture Fund XI, L.P. 10% owner 2024-02-08 Sale −267 $0.64 $171 734,546 I
Open-market sales · 1,000 sh · avg $0.64 · $640
Loading xslF345X05/doc4.xml…